AcipHex (Eisai Inc.)
Welcome to the PulseAid listing for the AcipHex drug offered from Eisai Inc.. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eisai Inc. |
NON-PROPRIETARY NAME: | rabeprazole sodium |
SUBSTANCE NAME: | RABEPRAZOLE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, DELAYED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1999-08-19 |
END MARKETING DATE: | 0000-00-00 |
AcipHex HUMAN PRESCRIPTION DRUG Details:
Item Description | AcipHex from Eisai Inc. |
LABELER NAME: | Eisai Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 1999-08-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62856-243_af7b14d0-98ac-4926-a3ee-5e1b3866d13b |
PRODUCT NDC: | 62856-243 |
APPLICATION NUMBER: | NDA020973 |
Other RABEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers: